Dep.Obstet-Gynec.-Reproduction,Institut Universitari Dexeus
Barcelona, 8028, Spain
NCT Number: NCT01785095
The purpose of the study is to evaluate immunogenic potential of FSH-IBSA in healthy volunteers undergoing controlled ovarian hyperstimulation (COH) in an oocyte donation program.
Looking for future studies?
Notify Me18 year–35 year
Female
Interventional
Phase 3
Barcelona, 8028, Spain
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 4 months.
The immunogenicity potential of FSH in healthy volunteer will be assessed by analysing serum samples collected at different timepoints during two treatment cycle for oocytes donation: cycle 1, serum samples will be collected before treatment start (baseline), after 7-13 days and after 28 days of treatment; Cycle 2: serum samples will be collected before starting the second cycle (baseline 2), after 7-13 days and after 28 days of treatment. Cycle 1 and cycle 2 will be separated by a wash-out period of two months.
Time frame: after 2 weeks of treatment
the number of oocytes retrieved in the first cycle and in the second cycle are compared.
Time frame: after 2 weeks of treatment
IBSA Institut Biochimique SA
Industry
Prospective, Open-label, Uncontrolled Clinical Trial Evaluating Multiple Controlled Ovarian Hyperstimulation Cycles in Oocyte Donor, to Assess the Immunogenicity of FSH-IBSA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03668184
Oocyte Donation, Pregnancy
Rennes, France
View Trial DetailsNCT02490150
Oocyte Donation
Barcelona, Spain
View Trial DetailsNCT01645241
Fertility Preservation, Genital Diseases
Barcelona, Spain
View Trial DetailsNCT07263490
ART, Abruptio Placentae
Copenhagen, Denmark
View Trial Details